MEDOCANN Group

The Medocann Group, co-founded & managed by the 4th generation of a family with a rich agricultural heritage, operates a state-of-the-art indoor breeding, propagation & cultivation facility on the family estate in central Israel. The facility, a convergence of high-tech, ag-tech and pharma-tech, provides best-in-class, safe and consistent medical-grade cannabis based on Medocann’s extensive in-house bank of genetic strains. Medocann’s cannabis is grown with care in a fully controlled environment, without the use of pesticides or insecticides. Medocann’s proprietary genetics bank provides our customers with access to a wide range of in-house genetic solutions to choose from. COLLABORATION OPPORTUNITIES: 1) GLOBAL IMPORTERS & DISTRIBUTORS are invited to contact us to discuss import & distribution of Medocann's branded line of Best-In-Class Cannabis in their markets. 2) Medocann provides PRODUCT DEVELOPERS & MANUFACTURERS with superior, precise cannabis ingredients customized to specific product formulations & genetic requirements. 3) CLINICAL RESEARCHERS are invited to contact Medocann for clinical trial collaborations. "Everything we do at Medocann is based on our unwavering commitment to only the highest quality cannabis that meets and exceeds the requirements of the most stringent regulatory environments in the world, and the most discerning customers." - Asaf Sella, Medocann CEO